P45 Frequency of HCV resistance associated substitutions at baseline and relapse
Main Authors: | J. O’Keefe, A. Thompson, T. Papaluca, S. Bowden |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-08-01
|
Series: | Journal of Virus Eradication |
Online Access: | http://www.sciencedirect.com/science/article/pii/S205566402030786X |
Similar Items
-
Compartmentalization of Resistance-Associated Substitutions in HIV/HCV-Infected Patients: Possible Correlation with Infecting HCV Genotype
by: Giulia Morsica, et al.
Published: (2021-07-01) -
Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant
by: Perales C, et al.
Published: (2018-11-01) -
Geographic Distribution of HCV-GT3 Subtypes and Naturally Occurring Resistance Associated Substitutions
by: Sabrina Bagaglio, et al.
Published: (2019-02-01) -
Whole-genome characterization and resistance-associated substitutions in a new HCV genotype 1 subtype
by: von Massow G, et al.
Published: (2019-04-01) -
Detection of a genetic footprint of the sofosbuvir resistance-associated substitution S282T after HCV treatment failure
by: Andreas Walker, et al.
Published: (2017-06-01)